Pharm Intermeidates |
| No |
English Name |
CAS NO. |
Specification |
Therapy |
| 1 |
Tetrahydropapaverine HCL |
6429-4-5 |
In-House Standard |
Atracurium Besilate Intermediate |
| 2 |
1,5- Pentamethylene diacrylate |
36840-85-4 |
In-House Standard |
Atracurium Besilate Intermediate |
| 3 |
Atracurium Oxalate |
64228-78-0 |
In-House Standard |
Atracurium Besilate Intermediate |
| 4 |
R-Tetrahydropapaverine-N-acetyl-L-leucinate |
141109-12-8 |
In-House Standard |
Cisatracurium Intermediate |
| 5 |
(1R,1'R)-2,2'-(3,11-dioxatridecamethylene)-bis-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline) dioxalate(Cisatracurium Oxalate) |
96687-52-4 |
In-House Standard |
Cisatracurium Intermediate |
| 6 |
1,2,3- 3-O-Acetyl-5-Deoxy-D-Ribofuranose |
62211-93-2 |
In-House Standard |
Capecitabine intermediate |
| 7 |
2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine |
161599-46-8 |
In-House Standard |
Capecitabine intermediate |
| 8 |
2-s-Thiuronium ethanesulfonate |
108710-70-9 |
In-House Standard |
Mesna Intermediate |
| 9 |
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate |
162204-20-8 |
In-House Standard |
Capecitabine intermediate |
| 10 |
(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol |
188399-48-6 |
In-House Standard |
Entecavir intermediate |
| 11 |
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy) -2-(benzyloxymethyl) cyclopentanol |
142217-77-4 |
In-House Standard |
Entecavir intermediate |
| 12 |
2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
142217-81-0 |
In-House Standard |
Entecavir intermediate |
| 13 |
4,5-dimethoxy-1,2-dihydrocyclobutabenzene-1-carbonitrile |
35202-54-1 |
In-House Standard |
Ivabradine HCL Intermediate |
| 14 |
(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutanehydrochloride |
866783-13-3 |
In-House Standard |
Ivabradine HCL Intermediate |
| 15 |
3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-one |
85175-59-3 |
In-House Standard |
Ivabradine HCL Intermediate |
| 16 |
1,3-Dihydro-3-(3-iodopropyl)-7,8-dimethoxy-2H-3-Benzazepin-2-one |
148870-57-9 |
In-House Standard |
Ivabradine HCL Intermediate |
| 17 |
Fludarabine Base |
21679-14-1 |
In-House Standard |
Fludarabine Phosphate Intermediate |
| 18 |
3',5'-Di-O-acetyl-2-fluoro-2'-O-trifluoro-methanesulfonyladenosine |
161109-76-8 |
In-House Standard |
Fludarabine Phosphate Intermediate |
| 19 |
2-Fluoro-2',3',5'-Trioxo-Acetyl Adenosine |
15811-32-2 |
In-House Standard |
Fludarabine Phosphate Intermediate |
| 20 |
2',3',5'-tri-O-acetyl-6-chloroguanosine |
16321-99-6 |
In-House Standard |
Fludarabine Phosphate Intermediate |